Gregor C - Search Results

1

Medications requiring prior authorization across health insurance plans.

Jones LK, Ladd IG, Gionfriddo MR, Gregor C, Evans MA, Graham J. Jones LK, et al. Among authors: gregor c. Am J Health Syst Pharm. 2020 Apr 1;77(8):644-648. doi: 10.1093/ajhp/zxaa031. Am J Health Syst Pharm. 2020. PMID: 32123921

2

Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system.

Jones LK, Ladd IG, Gregor C, Evans MA, Graham J, Gionfriddo MR. Jones LK, et al. Among authors: gregor c. Am J Health Syst Pharm. 2019 Mar 19;76(7):453-459. doi: 10.1093/ajhp/zxy083. Am J Health Syst Pharm. 2019. PMID: 31361821

3

Evaluating implementation outcomes (acceptability, adoption, and feasibility) of two initiatives to improve the medication prior authorization process.

Jones LK, Ladd IG, Gregor C, Evans MA, Graham J, Gionfriddo MR. Jones LK, et al. Among authors: gregor c. BMC Health Serv Res. 2021 Nov 20;21(1):1259. doi: 10.1186/s12913-021-07287-2. BMC Health Serv Res. 2021. PMID: 34801025 Free PMC article.

4

Community Pharmacists' Perceptions of Care Following the Implementation of a Transitions-of-Care Program.

Graham J, Tusing LD, Gregor CM, Wright EA. Graham J, et al. J Pharm Pract. 2020 Oct;33(5):586-591. doi: 10.1177/0897190018824819. Epub 2019 Jan 22. J Pharm Pract. 2020. PMID: 30669931

5

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis.

Jones LK, Tilberry S, Gregor C, Yaeger LH, Hu Y, Sturm AC, Seaton TL, Waltz TJ, Rahm AK, Goldberg A, Brownson RC, Gidding SS, Williams MS, Gionfriddo MR. Jones LK, et al. Among authors: gregor c. Implement Sci. 2021 Apr 13;16(1):40. doi: 10.1186/s13012-021-01108-0. Implement Sci. 2021. PMID: 33849601 Free PMC article. Review.

6

The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis.

Andrick B, Tusing L, Jones LK, Hu Y, Sneidman R, Gregor C, Basu S, Lynch JP, Vadakara J. Andrick B, et al. Among authors: gregor c. Transplant Cell Ther. 2022 Jun;28(6):334.e1-334.e9. doi: 10.1016/j.jtct.2022.02.015. Epub 2022 Feb 18. Transplant Cell Ther. 2022. PMID: 35189400 Free article.

7

Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.

Jones LK, Gidding SS, Seaton TL, Goldberg A, Gregor C, Sturm AC, Brownson RC, Rahm AK, Williams MS. Jones LK, et al. Among authors: gregor c. Res Social Adm Pharm. 2020 Mar;16(3):390-395. doi: 10.1016/j.sapharm.2019.06.006. Epub 2019 Jun 15. Res Social Adm Pharm. 2020. PMID: 31229402 Free PMC article.

8

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.

Jones LK, Sturm AC, Seaton TL, Gregor C, Gidding SS, Williams MS, Rahm AK. Jones LK, et al. Among authors: gregor c. PLoS One. 2020 Dec 23;15(12):e0244193. doi: 10.1371/journal.pone.0244193. eCollection 2020. PLoS One. 2020. PMID: 33362269 Free PMC article.

9

Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up.

Wright EA, Graham JH, Maeng D, Tusing L, Zaleski L, Martin R, Seipp R, Citsay B, McDonald B, Bolesta K, Chaundy K, Medico CJ, Gunderman S, Leri F, Guza K, Price R, Gregor C, Parry DT. Wright EA, et al. Among authors: gregor c. J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):178-186. doi: 10.1016/j.japh.2018.11.005. Epub 2019 Jan 14. J Am Pharm Assoc (2003). 2019. PMID: 30655090

10

[in process].

Gregor C. Gregor C. Krankenpfl Soins Infirm. 2017;110(5):16-19. Krankenpfl Soins Infirm. 2017. PMID: 30300511 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page